Quest Diagnostics Inc vs Honeywell International Inc — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Honeywell International Inc trades at $230.1 (market cap $72.93B). The key difference: Honeywell International Inc is far larger — about 2.8× Quest Diagnostics Inc's market cap, and Quest Diagnostics Inc pays the higher dividend (1.45%). Which is the better fit depends on your goals.
| DGX | HON | |
|---|---|---|
Market Cap | $26.21B | $72.93B |
Sector | Health | Industrials |
52-Week High | $238.50 | $248.79 |
52-Week Low | $173.49 | $188.14 |
Enterprise Value | $31.97B | $97.73B |
Dividend Yield | 1.45% | 1.22% |
Trailing returns across standard periods
Latest headlines on both assets
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →